日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer.

MSN/STAT3 通过 IL-6/LPAR1 配体受体复合物驱动三阴性乳腺癌的干性和化疗耐药性

Lee Cheng Hyun, Park Soo Young, Lee Jae Seok, Kim Da Sol, Kim Ha Yeon, Song Min Ji, Im Seock-Ah, Lee Kyung-Hun, Lee Dae-Won, Nikas Ilias P, Koh Ji Won, Yang So Hyeon, Lee Hyebin, Ryu Han Suk

Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent

烟酰胺(烟酸)补充剂可增强三阴性乳腺癌细胞的脂质代谢并改善活性氧诱导的能量代谢紊乱:具有作为抗肿瘤药物的潜力

Minsun Jung ,Kyung-Min Lee ,Yebin Im ,Seung Hyeok Seok ,Hyewon Chung ,Da Young Kim ,Dohyun Han ,Cheng Hyun Lee ,Eun Hye Hwang ,Soo Young Park ,Jiwon Koh ,Bohyun Kim ,Ilias P Nikas ,Hyebin Lee ,Daehee Hwang ,Han Suk Ryu

Tryptophanyl-tRNA Synthetase Sensitizes Hormone Receptor-Positive Breast Cancer to Docetaxel-Based Chemotherapy

色氨酰-tRNA合成酶可增强激素受体阳性乳腺癌对多西他赛类化疗的敏感性

Lee, Kyung-Min; Hwang, Eun Hye; Kang, Seong Eun; Lee, Cheng Hyun; Lee, Hyebin; Oh, Hyeon Jeong; Kim, Kwangsoo; Koh, Jiwon; Ryu, Han Suk

Biomodification of PCL Scaffolds with Matrigel, HA, and SR1 Enhances De Novo Ectopic Bone Marrow Formation Induced by rhBMP-2

使用 Matrigel、HA 和 SR1 对 PCL 支架进行生物改性可增强 rhBMP-2 诱导的新生异位骨髓形成

Wenjing Bao, Mei Gao, Yanyan Cheng, Hyun Jae Lee, Qinghao Zhang, Susan Hemingway, Zhibo Luo, Andrzej Krol, Guanlin Yang, Jing An